Granite Bio Company
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Employee Number:
11-50
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Founded Date:
2021-01-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Investors:
Forbion Capital Partners, Novartis Venture Fund, Sanofi Ventures, Versant Ventures
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
Founders:
Matthias Mack